Evidence map›Paper›PMID 9488447›Full record

ArticleMolecular and cellular biology1998

ETS-core binding factor: a common composite motif in antigen receptor gene enhancers.

B Erman, M Cortes, B S Nikolajczyk, N A Speck, R Sen

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. Activation of MouseJournal of immunology (Baltimore, Md. : 1950) · 2017
    Article
  3. Article
  4. Article
  5. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.Frontiers in bioscience (Landmark edition) · 2012
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

B ErmanRosenstiel Research Center and Department of Biology, Brandeis University, Waltham, Massachusetts 02254, USA.
M Cortes
B S Nikolajczyk
N A Speck
R Sen
Brandeis University · USDartmouth College · US

Funding

BIOCHEMISTRY OF LEUKEMIA VIRUS CORE-BINDING FACTORR01CA058343 · NCI · DARTMOUTH COLLEGE · PI SPECK, NANCY ASMUSSEN · 1993 to 2007
$3.0M
REGULATION OF IMMUNOGLOBULIN GENE EXPRESSION IN B CELLSR01GM038925 · NIGMS · BRANDEIS UNIVERSITY · PI REN, RUIBAO · 1992 to 2003
$1.2M
FACTORS REGULATING IG GENE EXPRESSION IN B-CELLSR29GM038925 · NIGMS · BRANDEIS UNIVERSITY · PI SEN, RANJAN · 1987 to 1991
–
NCI NIH HHS CA58343NCI NIH HHS R01 CA058343NIGMS NIH HHS GM38925NIGMS NIH HHS R01 GM038925
6 · The paper itself

Abstract

A tripartite domain of the murine immunoglobulin mu heavy-chain enhancer contains the muA and muB elements that bind ETS proteins and the muE3 element that binds leucine zipper-containing basic helix-loop-helix (bHLH-zip) factors. Analysis of the corresponding region of the human mu enhancer revealed high conservation of the muA and muB motifs but a striking absence of the muE3 element. Instead of bHLH-zip proteins, we found that the human enhancer bound core binding factor (CBF) between the muA and mu elements; CBF binding was shown to be a common feature of both murine and human enhancers. Furthermore, mutant enhancers that bound prototypic bHLH-zip proteins but not CBF did not activate transcription in B cells, and conversely, CBF transactivated the murine enhancer in nonlymphoid cells. Taking these data together with the earlier analysis of T-cell-specific enhancers, we propose that ETS-CBF is a common composite element in the regulation of antigen receptor genes. In addition, these studies identify the first B-cell target of CBF, a protein that has been implicated in the development of childhood pre-B-cell leukemias.

Indexed as

Enhancer Elements, GeneticNeoplasm ProteinsAnimalsBase SequenceBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsB-LymphocytesCell ExtractsCell NucleusCore Binding FactorsDNA-Binding ProteinsHeLa CellsHumansImmunoglobulin Heavy ChainsImmunoglobulin mu-ChainsInterferon Regulatory Factor-4Interferon Regulatory FactorsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell ExtractsCore Binding FactorsDNA-Binding ProteinsImmunoglobulin Heavy ChainsImmunoglobulin mu-ChainsInterferon Regulatory Factor-4Interferon Regulatory FactorsNeoplasm ProteinsProto-Oncogene ProteinsProto-Oncogene Proteins c-etsReceptors, AntigenTFE3 protein, humanTrans-ActivatorsTranscription FactorsUpstream Stimulatory Factors

Identifiers

PMID9488447
PMCPMC108845
OpenAlexW2151360445

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.